Transdermal formulation for administering prazosin

Details Transdermal formulation for administering prazosin Transdermal formulation for administering prazosin

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61K 9/70 (2006.01) A61K 31/517 (2006.01) A61K 47/00 (2006.01) A61K 47/18 (2006.01) A61K 47/20 (2006.01) A61M 37/00 (2006.01)

Patent

CA 2115840

2115840 9303697 PCTABS00020 Prazosin is formulated in solution with a skin permeation enhancer composition of: a sulfhydryl-containing compound, a fatty acid ester, and a polar solvent for transdermal administration to treat hypertension or benign prostatic hypertrophy. The formulation is employed in the form of a skin patch (10) comprising (a) an impermeable backing layer (11), (b) a reservoir (12) of the prazosin-enhancer solution, (c) a porous support member (13) that retains the solution but is not a permeation barrier to the solution, a peripheral adhesive layer (14) for affixing the patch to the skin, and a release liner layer (15).

Affiliated with

Also associated with

Rating

Transdermal formulation for administering prazosin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal formulation for administering prazosin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal formulation for administering prazosin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1663890